Home › Trial NCT04264078
Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies
- Trial IDNCT04264078
- StatusUnknown
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorXinqiao Hospital of Chongqing
- Enrollment30
- Start date2021-03-01
- ConditionsT-cell Leukemia · T-cell Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.